Philogen S.p.A.
Stock Details
Is it expensive?
Market Cap
918.41M
Trailing P/E Ratio
3.93
Forward P/E Ratio
-55.63
PEG Ratio
-55.63
544.08M
2.09
Price-to-Sales (TTM)
2.82
7.17
3.13
Is it profitable?
319.73M
Net Profit Margin (TTM)
71.83%
Gross Profit Margin
0.00%
Diluted EPS (TTM)
5.70
89.63%
Is it growing?
310.80%
302.20%
Is it risky?
-0.00
2.92
10.93M
7.76
Who owns it?
10.63%
62.15%
0.00%
40.28M
10.75M
Does it pay?
3.09%
0.00%
May 18, 2026
--
How much cash?
379.22M
267.96M
201.54M
9.41
- Price (EOD)
- 23.00
- Percent Change
- -0.25 (1.08%)
- Previous Close
- 23.25
- Open
- --
- Low
- --
- High
- --
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
€23.00
From 52W Low
--
From 52W High
--
Today
-1.08%
1Y Change
--
Today
€23.00
From 52W Low
--
From 52W High
--
Today
-1.08%
1Y Change
--
Today
€23.00
Fairly Priced
within its 1-year price range
€23.00
Rate of Change (ROC)
Insufficient price history
- Name
- Philogen S.p.A.
- Founded
- 1996
- CEO
- Prof. Dario Neri
- Employees
- 201
- Fiscal Year End
- Dec 31, 2025
- Address
Piazza La Lizza #7
Siena
SI
53100
Italy
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.philogen.com
Indicators
Operating Cash Flow
267.96M
Net Income
229.68M
Backed by Cash
1.17
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
FTSE Italia Mid CapIndex FTSE Italia Mid Cap - ITMC |
Indicators
Operating Cash Flow
267.96M
Net Income
229.68M
Backed by Cash
1.17
Earnings closely match operating cash flow. This is the healthy baseline: profits are genuine and not artificially inflated.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
918.41M
Trailing P/E Ratio
3.93
Forward P/E Ratio
-55.63
PEG Ratio
-55.63
544.08M
2.09
Price-to-Sales (TTM)
2.82
7.17
3.13
Is it profitable?
319.73M
Net Profit Margin (TTM)
71.83%
Gross Profit Margin
0.00%
Diluted EPS (TTM)
5.70
89.63%
Is it growing?
310.80%
302.20%
Is it risky?
-0.00
2.92
10.93M
7.76
Who owns it?
10.63%
62.15%
0.00%
40.28M
10.75M
Does it pay?
3.09%
0.00%
May 18, 2026
--
How much cash?
379.22M
267.96M
201.54M
9.41
- Price (EOD)
- 23.00
- Percent Change
- -0.25 (1.08%)
- Previous Close
- 23.25
- Open
- --
- Low
- --
- High
- --
52-Week Range Position (52WRP)
Fairly Priced
Fairly Priced
within its 1-year price range
€23.00
From 52W Low
--
From 52W High
--
Today
-1.08%
1Y Change
--
Today
€23.00
From 52W Low
--
From 52W High
--
Today
-1.08%
1Y Change
--
Today
€23.00
Fairly Priced
within its 1-year price range
€23.00
Rate of Change (ROC)
Insufficient price history
- Name
- Philogen S.p.A.
- Founded
- 1996
- CEO
- Prof. Dario Neri
- Employees
- 201
- Fiscal Year End
- Dec 31, 2025
- Address
Piazza La Lizza #7
Siena
SI
53100
Italy
- GICS Classification
- Health Care›Pharmaceuticals, Biotechnology & Life Sciences›Biotechnology
- Website
- www.philogen.com
Related Heatmaps
FTSE Italia Mid CapIndex FTSE Italia Mid Cap - ITMC |